ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE CREATININA.
Mexico·Clase I·III. Agentes de
diagnóstico·SIEMENS HEALTHCARE
DIAGNOSTICS, S. DE R.L. DE
C.V.·Registered May 28, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ADVIA® CHEMISTRY ENZYMATIC CREATININE_3 (ECRE3)
- Trade Name (English)
- ADVIA® CHEMISTRY ENZYMATIC CREATININE_3 (ECRE3)
- Analysis ID
- 1581R2024 SSA
- Registration Date
- May 28, 2024
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE CREATININA. (ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE CREATININA.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1581R2024 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on May 28, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.